These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2471583)

  • 1. Increased sensitivity of quinone resistant cells to mitomycin C.
    Begleiter A; Robotham E; Lacey G; Leith MK
    Cancer Lett; 1989 Jun; 45(3):173-6. PubMed ID: 2471583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of quinone alkylating agents in quinone-resistant cells.
    Begleiter A; Leith MK
    Cancer Res; 1990 May; 50(10):2872-6. PubMed ID: 1692249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
    Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA
    Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.
    Halinska A; Belej T; O'Brien PJ
    Br J Cancer Suppl; 1996 Jul; 27():S23-7. PubMed ID: 8763840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
    Begleiter A; Robotham E; Leith MK
    Mol Pharmacol; 1992 Apr; 41(4):677-82. PubMed ID: 1373799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts.
    Begleiter A; Blair GW
    Cancer Res; 1984 Jan; 44(1):78-82. PubMed ID: 6537800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Dec; 50(23):7483-9. PubMed ID: 1701346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of trenimon-induced cytotoxicity in resistant L5178Y/HBM10 cells.
    Silva JM; O'Brien PJ
    Int J Radiat Oncol Biol Phys; 1992; 22(4):639-42. PubMed ID: 1371987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of alkylation to the activity of quinone antitumor agents.
    Begleiter A
    Can J Physiol Pharmacol; 1986 May; 64(5):581-5. PubMed ID: 3730943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual.
    Marshall RS; Paterson MC; Rauth AM
    Biochem Pharmacol; 1991 May; 41(9):1351-60. PubMed ID: 1902110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of action of quinone antitumor agents.
    Begleiter A
    Biochem Pharmacol; 1985 Aug; 34(15):2629-36. PubMed ID: 4015705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
    Roberts JJ; Marchbank T; Kotsaki-Kovatsi VP; Boland MP; Friedlos F; Knox RJ
    Biochem Pharmacol; 1989 Nov; 38(22):4137-43. PubMed ID: 2480794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
    Walton MI; Smith PJ; Workman P
    Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
    Schlager JJ; Powis G
    Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the antineoplastic efficacy of mitomycin C by dicoumarol in vivo.
    Rockwell S; Keyes SR; Sartorelli AC
    Cancer Chemother Pharmacol; 1989; 24(6):349-53. PubMed ID: 2477164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
    Begleiter A; Leith MK
    Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family.
    Marshall RS; Paterson MC; Rauth AM
    Carcinogenesis; 1991 Jul; 12(7):1175-80. PubMed ID: 1906377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytocidal action of the quinone group and its relationship to antitumor activity.
    Begleiter A
    Cancer Res; 1983 Feb; 43(2):481-4. PubMed ID: 6848172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].
    Nishiyama M; Saeki S; Aogi K; Hirabayashi N; Toge T
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1037-41. PubMed ID: 7685584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.